Yasuharu Kimura

Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species*

H. Akiho, M. Matsumoto, Tokio Yamaguchi, 1996, The Journal of Biological Chemistry.

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.

Tokio Yamaguchi, Akiko Koakutsu, Yasuharu Kimura, 2004, European journal of pharmacology.

5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.

Tokio Yamaguchi, Yasuharu Kimura, Y. Naitou, 2008, European journal of pharmacology.

Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.

S. Tsukamoto, K. Sugasawa, S. Sakamoto, 2008, Bioorganic & medicinal chemistry.

Characterization of intracavernous pressure increase induced by Ym348, a novel 5-HT2C receptor agonist, in anesthetized rats.

Tokio Yamaguchi, Yasuharu Kimura, Y. Naitou, 2006, The Journal of urology.

Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists.

S. Tsukamoto, S. Sakamoto, H. Kubota, 2008, Bioorganic & medicinal chemistry.

Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats

M. Sasamata, K. Miyata, Masanori Suzuki, 2004, Brain Research.

5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.

Tokio Yamaguchi, Yasuharu Kimura, Y. Naitou, 2008, European journal of pharmacology.